Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut ...

Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...

Kenvue (NYSE:KVUE) recently experienced a 2% price increase over the past week, a move that coincides with notable executive changes. The replacement of the CEO with Kirk L. Perry as interim CEO, ...

The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...